New retinal imaging software launched

Article

Optos has launched a new version of its proprietary retinal imaging software, V2 Vantage.

Optos has launched a new version of its proprietary retinal imaging software, V2 Vantage.

The unit's ResMax is a new capability that increases the image resolution of the macula and optic nerve while 3D Wrap allows the practitioner to create a three-dimensional representation of the human eye on to which the retinal exam is projected. This graphical capability allows complete visualization of the shape and location of disease, making it easier for patients to understand.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
An image of the European Medicines Agency (EMA) headquarters to accompany a CHMP opinion. Image credit: ©Lubo Ivanko – stock.adobe.com

EMA grants positive CHMP opinion for low-dose atropine SYD-101 (Ryjunea, Sydnexis)

Hattie Hayes
April 1st 2025
Article

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

An image of boxing gloves in a ring, hanging over an open flame. ©Image by Jennifer Toomey / MJH Life Sciences using AI

Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology

Hattie Hayes;Anat Loewenstein, MD;Baruch Kuppermann, MD, PhD
March 31st 2025
Article

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

An image of an intraocular lens (IOL) being lifted with a surgical device. Accommodative intraocular lens concept image for cataract and refractive surgery. Image credit: ©Wirestock – stock.adobe.com. In the lower right hand side is a photo of Editorial Advisory Board member and article author Jorge L. Alió, MD, PhD, FEBOphth, courtesy of Professor Alió.

Accommodative intraocular lenses: Are they coming back?

Jorge L. Alió, MD, PhD, FEBOphth, FWCRS
March 28th 2025
Article

A resurgence in this IOL technology could create new possibilities in refractive correction

A child with myopia is fitted for glasses in an optometrist or ophthalmologist or optician office. Concept for paediatric myopia and refractive correction. ©chomplearn_2001 – stock.adobe.com

Paediatric myopia study indicates lens thickness and power changes closely associated with age

Lynda Charters
March 28th 2025
Article

The study assessed a large paediatric cohort for changes in spherical equivalent refraction, axial length, lens power and lens thickness

© 2025 MJH Life Sciences

All rights reserved.